Minoxidil Treatment for Androgenetic Alopecia

Introduction to Minoxidil Therapy

The American Academy of Dermatology recommends topical minoxidil 5% as the first-line treatment for androgenetic alopecia, which must be continued indefinitely to maintain results 1
Topical minoxidil 5% has an application protocol of 1 mL twice daily for optimal results 3
Treatment with topical minoxidil must be indefinite, as discontinuation leads to complete reversal of hair growth benefits 1

The evidence base for topical minoxidil is robust, with efficacy ranging from 17% to 70% hair growth improvement depending on concentration 1
Topical minoxidil has a lower systemic adverse effect profile compared to oral formulation, and no cardiovascular screening is required before initiation 2
The American College of Cardiology explicitly recommends avoiding oral minoxidil in patients with existing cardiovascular conditions due to rare but serious adverse effects, including pericardial effusion 2

Oral minoxidil shows response rates of 18-82.4% in alopecia patients but carries substantial risks, including cardiovascular disease, and should only be considered for patients who fail topical therapy or cannot tolerate it 2
All patients must be screened for cardiovascular disease before initiating oral minoxidil, and low-dose oral minoxidil is defined as ≤5 mg/day with generally good tolerability in patients studied 2
Women require lower starting doses of oral minoxidil due to a significantly higher incidence of adverse effects compared to men 2

The highest efficacy comes from combining topical minoxidil with other treatments, such as PRP, rather than switching to oral monotherapy 1
PRP combined with topical minoxidil 5% is more effective than either treatment alone, showing the highest increase in hair density in comparative studies 1
The recommended protocol for combination therapy includes topical minoxidil 5% twice daily, PRP injections monthly for at least 3 sessions, and maintenance phase sessions every 6 months 1

Patients on oral minoxidil should be monitored for orthostatic vital signs, edema, heart rate and rhythm, and cardiovascular symptoms at each visit 2
For all patients on minoxidil therapy, standardized photographs, trichoscopy, patient self-assessment questionnaires, and hair pull tests should be used to evaluate treatment response at 3, 6, and 12 months 1